TNIP3

Across TCGA pan-cancer cohorts, TNIP3 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TNIP3 data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TNIP3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TNIP3 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

LUAD and LSCC are the cancer types where TNIP3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.522	0.915	.016	14	view →
LSCC	OS	Median	All	1.000	0.775	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TNIP3–LUAD (OS)

Open the LUAD breakdown →